Return to homepagePandemic Pact

COVID-19 Supplement #3 Moderna Trial

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2022

  • Known Financial Commitments (USD)

    $11,154,495

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    DANIEL F HOFT

  • Research Location

    United States of America

  • Lead Research Institution

    SAINT LOUIS UNIVERSITY

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Saint Louis University (SLU) seeks to expand its service to the Vaccine and TreatmentEvaluation Unit (VTEU) network providing resources and expertise to help the network achieveits objectives of evaluating vaccines, preventive biologics, therapeutics and diagnostics forCOVID-19.